Table 5.
Generalized linear model effect of TEG on reoperation for exploration of mediastinal bleeding and 6-month mortality (all cause).
| Reoperation | Pre-TEG, n (%) | Post-TEG, n (%) |
|---|---|---|
| Yes | 31 (4.8) | 7 (1.5) |
| No | 609 (95.2) | 451 (98.5) |
| Effect | Odds Ratio Estimate | 95% Confidence Limits |
| BMI | 1.01 | .96–1.07 |
| Charlson Comorbidity Index | 1.09 | .90–1.32 |
| Postoperative HGB (g/dL) | .84 | .50–1.40 |
| Postoperative HCT (%) | 1.15 | .97–1.37 |
| TEG | 2.98 | 1.21–7.35 |
| 6-Month Mortality* | Pre-TEG, n (%) | Post-TEG, n (%) |
| Yes | 13 (2.0) | 7 (1.5) |
| No | 619 (98.0) | 431 (98.5) |
| Effect | Odds Ratio Estimate | 95% Confidence Limits |
| BMI | 1.00 | .95–1.05 |
| Charlson Comorbidity Index | .70 | .57–.86 |
| Chest tube drainage | 1.00 | 1.00–1.00 |
| Postoperative HCT (%) | .79 | .63–.98 |
| Postoperative HGB (g/dL) | 2.37 | 1.29–4.36 |
| Postoperative platelet count (×109/L) | 1.00 | .99–1.01 |
| Coagulopathy | .42 | .13–1.35 |
| TEG (0 vs. 1) | 1.15 | .41–3.17 |
*
Alive status was unknown and removed from analysis in 6 cases pre-TEG and 21 cases post-TEG.